Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Study to Evaluate Safety, Tolerability, Pharmacometrics, and Efficacy of DNTH103 in Adults With Multifocal Motor Neuropathy (MOMENTUM)

The purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of Claseprubart (DNTH103) in participants with multifo…

Multifocal Motor Neuropathy

Estimated

~$10 – $8,750

Dianthus TherapeuticsNCT06537999